Convergence Investment Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-191
| Closed | -$201K | – | 280 |
|
|
2024
Q2 | $201K | Buy |
+191
| New | +$201K | 0.06% | 237 |
|
|
2023
Q4 | – | Sell |
-298
| Closed | -$245K | – | 206 |
|
|
2023
Q3 | $245K | Buy |
+298
| New | +$245K | 0.14% | 129 |
|
|
2022
Q3 | – | Sell |
-627
| Closed | -$371K | – | 242 |
|
|
2022
Q2 | $371K | Sell |
627
-91
| -13% | -$53.8K | 0.22% | 105 |
|
|
2022
Q1 | $501K | Buy |
718
+98
| +16% | +$68.4K | 0.26% | 98 |
|
|
2021
Q4 | $392K | Buy |
+620
| New | +$392K | 0.2% | 117 |
|
|
2018
Q2 | – | Sell |
-119
| Closed | -$41K | – | 762 |
|
|
2018
Q1 | $41K | Buy |
+119
| New | +$41K | 0.01% | 470 |
|